Systems (Nasdaq:KRMD) announced today that it signed a development agreement with a global pharmaceutical company.

KORU Medical Systems, Inc. ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric ...

Systems announced the signing of an agreement with a global pharmaceutical company. The agreement is intended for KORU ...

The FDA has approved a third biosimilar for tocilizumab, called Avtozma, the second such biosimilar to be available in both intravenous and subcutaneous formulations, according to a press release.

UCB, a global biopharmaceutical company, today announced the CHMP (Committee for Medicinal Products for Human Use) has issued a positive opinion for the self-administration of RYSTIGGO® ...

KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the ...

A 14-gauge needle in the valve to check the draw and return of blood and to flush with a heparinized saline solution prior to fixing the unit in the subcutaneous pocket. Cannulation of the valve ...

Subcutaneous administration can reduce time spent in infusion centers, enhancing patient quality of life ... located in New York City. Intravenous (IV): when a needle is inserted into a vein to ...

Based on this system, its primary products include the FREEDOM60 and FreedomEdge Syringe Infusion Drivers, Precision Flow Rate Tubing and HIgH-Flo Subcutaneous Safety Needle Sets. Shares in KORU ...

About the Insignis Infusion System The Insignis Syringe Infusion System is a robust, non-electric device designed for routine subcutaneous and intravenous medication delivery. Portable ...

The Insignis Syringe Infusion System is a robust, non-electric device designed for routine subcutaneous and intravenous medication delivery. Portable, lightweight, accurate, and easy to use ...